Author

Anthony J. Mutsaers

Observed names: A. J. Mutsaers, A. Mutsaers, A.J. Mutsaers, AJ MUTSAERS, Anthony J Mutsaers, Anthony Mutsaers, Mutsaers, Anthony, Mutsaers, Anthony J.

Institution: University of Guelph

Observed institutions: Sunnybrook Health Science Centre, The University of Queensland, The University of Melbourne, University of Toronto, Purdue University West Lafayette, London Health Sciences Centre, University of Florida, St Vincent's Hospital Melbourne, Ontario Veterinary College, St Vincents Institute of Medical Research, University of Guelph

ORCID: 0000-0002-7965-7149

Observed ORCID: 0000-0002-7965-7149

OpenAlex ID: A5020086814

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

2007 · John M. L. Ebos, Christina R. Lee, et al. · Proceedings of the National Academy of Sciences · 367

Canine Transitional Cell Carcinoma

2003 · Anthony J Mutsaers, William R Widmer, et al. · Journal of Veterinary Internal Medicine · 283

PDF

Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?

2014 · Anthony J. Mutsaers, Carl R. Walkley · Bone · 232

Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

2002 · Sulma I Mohammed, Peter F Bennett, et al. · PubMed · 199

Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs

2004 · Pedro A. Boria, Daryl J. Murry, et al. · Journal of the American Veterinary Medical Association · 133

Vascular Endothelial Growth Factor–Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth

2008 · John M.L. Ebos, Christina R. Lee, et al. · Cancer Research · 114

Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder

2005 · P. A. Boria, N. W. Glickman, et al. · Veterinary and Comparative Oncology · 95

Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2

2010 · Roni Mamluk, Irvith M. Carvajal, et al. · mAbs · 78

PDF

Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA

2013 · Anthony J. Mutsaers, Alvin J.M. Ng, et al. · Bone · 74

PDF

Systematic Screening Identifies Dual PI3K and mTOR Inhibition as a Conserved Therapeutic Vulnerability in Osteosarcoma

2015 · Ankita Gupte, Emma K. Baker, et al. · Clinical Cancer Research · 70

Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam

2004 · V LANGOVA, AJ MUTSAERS, et al. · Australian Veterinary Journal · 70

Metronomic Chemotherapy

2009 · Anthony J. Mutsaers · Topics in companion animal medicine · 64

Synthesis of curcumin-functionalized gold nanoparticles and cytotoxicity studies in human prostate cancer cell line

2018 · Shruti Nambiar, Ernest Osei, et al. · Applied Nanoscience · 62

Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs

2002 · Anthony J. Mutsaers, Nita W. Glickman, et al. · Journal of the American Veterinary Medical Association · 60

Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation

2019 · Mohamed Aborig, Paul R. V. Malik, et al. · Pharmaceutics · 58

PDF

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

2021 · Amy K. LeBlanc, Christina N. Mazcko, et al. · Clinical Cancer Research · 55

PDF

Preclinical mouse models of osteosarcoma

2015 · Özge Uluçkan, Aude Segaliny, et al. · BoneKEy Reports · 46

Genetically engineered mouse models and human osteosarcoma

2012 · Alvin JM Ng, Anthony J Mutsaers, et al. · Clinical Sarcoma Research · 45

PDF

The DNA Helicase Recql4 Is Required for Normal Osteoblast Expansion and Osteosarcoma Formation

2015 · Alvin J. M. Ng, Mannu K. Walia, et al. · PLoS Genetics · 44

PDF

Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs

2016 · Jerome Calvalido, Geoffrey A. Wood, et al. · Veterinary Immunology and Immunopathology · 41

The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells

2018 · Courtney R. Schott, Latasha Ludwig, et al. · PLoS ONE · 40

PDF

MicroRNA profiling in canine multicentric lymphoma

2019 · Karlee K. L. Craig, Geoffrey A. Wood, et al. · PLoS ONE · 39

PDF

Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma

2017 · Arata Matsuyama, Valerie J. Poirier, et al. · Journal of the American Animal Hospital Association · 36

Dose-Dependent Increases in Circulating TGF-α and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent

2009 · Anthony J. Mutsaers, Giulio Francia, et al. · Clinical Cancer Research · 34

Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells

2021 · Jordon M. Inkol, Samuel E. Hocker, et al. · PLoS ONE · 30

PDF

Works count: 112

Citation count: 2,918

H-index: 28

I10-index: 50